Sesen Bio, Inc.
(NASDAQ : EBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.42%179.111.2%$610.46m
CELGCelgene Corporation
1.23%77.551.2%$572.22m
GILDGilead Sciences, Inc.
0.33%68.050.9%$552.74m
BIIBBiogen Inc.
1.33%283.411.2%$527.56m
REGNRegeneron Pharmaceuticals, Inc.
0.00%294.682.6%$308.54m
ILMNIllumina, Inc.
0.19%271.323.5%$235.81m
VRTXVertex Pharmaceuticals Incorporated
-0.04%156.221.9%$230.33m
ALXNAlexion Pharmaceuticals, Inc.
-0.89%117.962.0%$222.94m
AAgilent Technologies, Inc.
-0.58%64.471.5%$209.55m
NKTRNektar Therapeutics
0.06%82.006.0%$198.43m
INCYIncyte Corporation
0.17%66.672.5%$176.93m
SRPTSarepta Therapeutics, Inc.
-0.88%88.4416.6%$123.92m
BMRNBioMarin Pharmaceutical Inc.
2.04%89.404.4%$119.73m
EXASExact Sciences Corporation
-3.45%51.1625.5%$112.06m
BLUEBluebird Bio, Inc.
1.45%188.3515.7%$96.10m

Company Profile

Sesen Bio, Inc. engages in biologic oncology development focuses on designing, engineering and developing targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.